US biotech Dewpoint Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...
IND opening marks culmination of partnership between Dewpoint and Evotec, advancing a de novo development candidate through ...
GlobalData on MSN
Dewpoint receives FDA orphan drug designation for DPTX3186
The ODD programme incentivises the development of medicines for conditions affecting fewer than 200,000 individuals in the US ...
This article was reviewed by Felix Gussone, MD. How Long Does Enclomiphene Stay in Your System? Testosterone plays a major ...
The U.S. FDA has granted orphan drug designation to Dewpoint Therapeutics Inc.’s DPTX-3186, its first-in-class condensate ...
In the rapidly advancing field of microelectronics manufacturing, the demand for higher throughput and precision in via drilling has never been greater. This translates into a market demand for more ...
Akari Therapeutics is advancing its research on a novel spliceosome modulator, PH1, which has shown potential in killing cancer cells and activating the immune system. The company is focusing on the ...
Dewpoint Therapeutics Inc. has announced an IND in the U.S. for DPTX-3186, a first-in-class oral condensate modulator ...
NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--HyperLight, the leading provider of integrated electro-optical modulators (EOMs), is proud to announce the expansion of its intensity modulator series. This ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--HyperLight, creator of the TFLN Chiplet™ platform, today announced the launch of its groundbreaking 110 GHz Low Vπ Intensity Modulator, featuring industry-standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback